Cargando…

Prognostic Nomograms for Predicting Overall Survival and Cancer‐Specific Survival of Patients With Malignant Pheochromocytoma and Paraganglioma

BACKGROUND: Malignant pheochromocytoma and paraganglioma (PPGL) are rare tumors with few prognostic tools. This study aimed to construct nomograms for predicting 3- and 5-year survival for patients with malignant PPGL. METHODS: The patient data was retrieved from the Surveillance, Epidemiology, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Lei, Gu, Yalong, Silang, Jiangcun, Wang, Jinlong, Luo, Feng, Zhang, Baopeng, Li, Chuanhong, Wang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257089/
https://www.ncbi.nlm.nih.gov/pubmed/34234744
http://dx.doi.org/10.3389/fendo.2021.684668
_version_ 1783718232029396992
author Zheng, Lei
Gu, Yalong
Silang, Jiangcun
Wang, Jinlong
Luo, Feng
Zhang, Baopeng
Li, Chuanhong
Wang, Feng
author_facet Zheng, Lei
Gu, Yalong
Silang, Jiangcun
Wang, Jinlong
Luo, Feng
Zhang, Baopeng
Li, Chuanhong
Wang, Feng
author_sort Zheng, Lei
collection PubMed
description BACKGROUND: Malignant pheochromocytoma and paraganglioma (PPGL) are rare tumors with few prognostic tools. This study aimed to construct nomograms for predicting 3- and 5-year survival for patients with malignant PPGL. METHODS: The patient data was retrieved from the Surveillance, Epidemiology, and End Results (SEER) database. A total of 764 patients diagnosed with malignant PPGL from 1975 to 2016 were included in this study. The patients were randomly divided into two cohorts; the training cohort (n = 536) and the validation cohort (n = 228). Univariate analysis, Lasso regression, and multivariate Cox analysis were used to identify independent prognostic factors, which were then utilized to construct survival nomograms. The nomograms were used to predict 3- and 5-year overall survival (OS) and cancer-specific survival (CSS) for patients with malignant PPGL. The prediction accuracy of the nomogram was assessed using the concordance index (C-index), receiver operating characteristic (ROC) curves and calibration curves. Decision curve analysis (DCAs) was used to evaluate the performance of survival models. RESULTS: Age, gender, tumor type, tumor stage, or surgery were independent prognostic factors for OS in patients with malignant PPGL, while age, tumor stage, or surgery were independent prognostic factors for CSS (P <.05). Based on these factors, we successfully constructed the OS and CSS nomograms. The C-indexes were 0.747 and 0.742 for the OS and CSS nomograms, respectively. In addition, both the calibration curves and ROC curves for the model exhibited reliable performance. CONCLUSION: We successfully constructed nomograms for predicting the OS and CSS of patients with malignant PPGL. The nomograms could inform personalized clinical management of the patients.
format Online
Article
Text
id pubmed-8257089
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82570892021-07-06 Prognostic Nomograms for Predicting Overall Survival and Cancer‐Specific Survival of Patients With Malignant Pheochromocytoma and Paraganglioma Zheng, Lei Gu, Yalong Silang, Jiangcun Wang, Jinlong Luo, Feng Zhang, Baopeng Li, Chuanhong Wang, Feng Front Endocrinol (Lausanne) Endocrinology BACKGROUND: Malignant pheochromocytoma and paraganglioma (PPGL) are rare tumors with few prognostic tools. This study aimed to construct nomograms for predicting 3- and 5-year survival for patients with malignant PPGL. METHODS: The patient data was retrieved from the Surveillance, Epidemiology, and End Results (SEER) database. A total of 764 patients diagnosed with malignant PPGL from 1975 to 2016 were included in this study. The patients were randomly divided into two cohorts; the training cohort (n = 536) and the validation cohort (n = 228). Univariate analysis, Lasso regression, and multivariate Cox analysis were used to identify independent prognostic factors, which were then utilized to construct survival nomograms. The nomograms were used to predict 3- and 5-year overall survival (OS) and cancer-specific survival (CSS) for patients with malignant PPGL. The prediction accuracy of the nomogram was assessed using the concordance index (C-index), receiver operating characteristic (ROC) curves and calibration curves. Decision curve analysis (DCAs) was used to evaluate the performance of survival models. RESULTS: Age, gender, tumor type, tumor stage, or surgery were independent prognostic factors for OS in patients with malignant PPGL, while age, tumor stage, or surgery were independent prognostic factors for CSS (P <.05). Based on these factors, we successfully constructed the OS and CSS nomograms. The C-indexes were 0.747 and 0.742 for the OS and CSS nomograms, respectively. In addition, both the calibration curves and ROC curves for the model exhibited reliable performance. CONCLUSION: We successfully constructed nomograms for predicting the OS and CSS of patients with malignant PPGL. The nomograms could inform personalized clinical management of the patients. Frontiers Media S.A. 2021-06-21 /pmc/articles/PMC8257089/ /pubmed/34234744 http://dx.doi.org/10.3389/fendo.2021.684668 Text en Copyright © 2021 Zheng, Gu, Silang, Wang, Luo, Zhang, Li and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Zheng, Lei
Gu, Yalong
Silang, Jiangcun
Wang, Jinlong
Luo, Feng
Zhang, Baopeng
Li, Chuanhong
Wang, Feng
Prognostic Nomograms for Predicting Overall Survival and Cancer‐Specific Survival of Patients With Malignant Pheochromocytoma and Paraganglioma
title Prognostic Nomograms for Predicting Overall Survival and Cancer‐Specific Survival of Patients With Malignant Pheochromocytoma and Paraganglioma
title_full Prognostic Nomograms for Predicting Overall Survival and Cancer‐Specific Survival of Patients With Malignant Pheochromocytoma and Paraganglioma
title_fullStr Prognostic Nomograms for Predicting Overall Survival and Cancer‐Specific Survival of Patients With Malignant Pheochromocytoma and Paraganglioma
title_full_unstemmed Prognostic Nomograms for Predicting Overall Survival and Cancer‐Specific Survival of Patients With Malignant Pheochromocytoma and Paraganglioma
title_short Prognostic Nomograms for Predicting Overall Survival and Cancer‐Specific Survival of Patients With Malignant Pheochromocytoma and Paraganglioma
title_sort prognostic nomograms for predicting overall survival and cancer‐specific survival of patients with malignant pheochromocytoma and paraganglioma
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257089/
https://www.ncbi.nlm.nih.gov/pubmed/34234744
http://dx.doi.org/10.3389/fendo.2021.684668
work_keys_str_mv AT zhenglei prognosticnomogramsforpredictingoverallsurvivalandcancerspecificsurvivalofpatientswithmalignantpheochromocytomaandparaganglioma
AT guyalong prognosticnomogramsforpredictingoverallsurvivalandcancerspecificsurvivalofpatientswithmalignantpheochromocytomaandparaganglioma
AT silangjiangcun prognosticnomogramsforpredictingoverallsurvivalandcancerspecificsurvivalofpatientswithmalignantpheochromocytomaandparaganglioma
AT wangjinlong prognosticnomogramsforpredictingoverallsurvivalandcancerspecificsurvivalofpatientswithmalignantpheochromocytomaandparaganglioma
AT luofeng prognosticnomogramsforpredictingoverallsurvivalandcancerspecificsurvivalofpatientswithmalignantpheochromocytomaandparaganglioma
AT zhangbaopeng prognosticnomogramsforpredictingoverallsurvivalandcancerspecificsurvivalofpatientswithmalignantpheochromocytomaandparaganglioma
AT lichuanhong prognosticnomogramsforpredictingoverallsurvivalandcancerspecificsurvivalofpatientswithmalignantpheochromocytomaandparaganglioma
AT wangfeng prognosticnomogramsforpredictingoverallsurvivalandcancerspecificsurvivalofpatientswithmalignantpheochromocytomaandparaganglioma